BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4392712)

  • 1. Anti-pneumococcal polysaccharide type 3 hemolytic plaques in mice: cellular response in immunity and immunologic paralysis.
    Kerman R; Segre D
    J Immunol; 1970 May; 104(5):1262-6. PubMed ID: 4392712
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):481-92. PubMed ID: 4396489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharide.
    Kotlarski I; Courtenay BM; Howard JG
    Eur J Immunol; 1973 Aug; 3(8):496-502. PubMed ID: 4148233
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.
    Baker PJ; Barth RF; Stashak PW; Amsbaugh DF
    J Immunol; 1970 May; 104(5):1313-5. PubMed ID: 4392713
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyl-lysine-substituted pneumococcal polysaccharide (SIII) and levan.
    Klaus GG; Humphrey JH
    Eur J Immunol; 1974 May; 4(5):370-7. PubMed ID: 4153121
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of immune and natural specific antibodies in immunologic paralysis and immunity of mice to pneumococcal polysaccharide type 3.
    Kerman R; Segre D; Myers WL
    J Immunol; 1970 Mar; 104(3):656-64. PubMed ID: 4190969
    [No Abstract]   [Full Text] [Related]  

  • 8. Treadmill neutralization of antibody and central inhibition. Separate components of pneumococcal polysaccharide paralysis.
    Howard JG; Christie GH; Courtenay BM
    Transplantation; 1970 Oct; 10(4):251-3. PubMed ID: 4396243
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):469-80. PubMed ID: 4396488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide.
    Braley-Mullen H
    J Immunol; 1974 Dec; 113(6):1909-20. PubMed ID: 4154347
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B; Barth RF
    J Immunol; 1970 Dec; 105(6):1581-3. PubMed ID: 4394909
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on immunological paralysis. 3. Recirculation and antibody-neutralizing activity of 14C-labelled type 3 pneumococcal polysaccharide in paralysed mice.
    Howard JG; Christie GH; Jacob MJ; Elson J
    Clin Exp Immunol; 1970 Oct; 7(4):583-96. PubMed ID: 4394510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on immunological paralysis. 8. Pneumococcal polysaccharide tolerance and immunity differences between the Biozzi high and low responder lines of mice.
    Howard JG; Christie GH; Courtenay BM; Biozzi G
    Eur J Immunol; 1972 Jun; 2(3):269-73. PubMed ID: 4405751
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: The basis for conflicting results obtained in studies on the plaque-forming cell response to type III pneumococcal polysaccharide.
    Baker PJ; Prescott B
    J Immunol; 1975 Sep; 115(3):891-2. PubMed ID: 239066
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological paralysis of mice with pneumococcal polysaccharide antigens.
    Halliday WJ
    Bacteriol Rev; 1971 Sep; 35(3):267-89. PubMed ID: 4398890
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.
    Baker PH; Stashak PW
    J Immunol; 1969 Dec; 103(6):1342-8. PubMed ID: 4391281
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.
    Baker PJ; Prescott B; Stashak PW; Amsbaugh DF
    J Immunol; 1971 Sep; 107(3):719-24. PubMed ID: 4398381
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3.
    Coutinho A; Möller G
    Eur J Immunol; 1973 Oct; 3(10):608-13. PubMed ID: 4148779
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the immune response of congenitally athymic (nude) mice.
    Jutila JW; Reed ND; Isaak DD
    Birth Defects Orig Artic Ser; 1975; 11(1):522-7. PubMed ID: 238688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antigen-specific immunologic paralysis induced by a single low dose of polyvinylpyrrolidone.
    Lake JP; Reed ND
    J Reticuloendothel Soc; 1976 Oct; 20(4):307-16. PubMed ID: 62838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.